Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
11/2003
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645985 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them, and method of treating
11/11/2003US6645956 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment
11/11/2003US6645259 Cationic aminoanthraquinones, their use for dyeing keratinous fibers, dyeing compositions containing them and methods of dyeing
11/11/2003US6645258 Oxidation base selected from a 3-substituted 4,5-diaminopyrazoles; reacting
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091221A1 Celecoxib forms
11/06/2003WO2003091211A1 Novel heteroaryl compounds
11/06/2003WO2003090730A1 Novel crystalline forms of celecoxib and other compounds
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003WO2003035005A3 Heteroindanes: a new class of potent cannabimimetic ligands
11/06/2003US20030208082 Nitrogen compounds such as 4,5-diisopropyl-1-methyl-2-styryl -1H-imidazole, used as glutamate receptor antagonists, for prophylaxis of psychological disorders, as anxiolytic agents and analgesics
11/06/2003US20030207939 Novel 3-substituted urea derivatives and medicinal use thereof
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207874 Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003EP1358189A1 Process for the preparation of a pyrazolo 4,3-d]pyrimidine derivative
11/05/2003EP1358164A1 Method of producing 1-alkyl-3-aryl-5-difluoromethoxy-1h-pyrazoles
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1126753C Pyrazolo (3,4-D) pyrimidines for anticonvulsive and antialiergic/antiasthmatic action
11/05/2003CN1126543C Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003CA2272483C Pyrazoles
10/2003
10/30/2003WO2003088968A1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003088927A2 Novel curcumin analogues and uses thereof
10/30/2003WO2003051833A3 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
10/30/2003WO2003037274A3 Pyrazole-amides and-sulfonamides
10/30/2003WO2003026415A3 Insecticidal diamides
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002066425A3 Compositions and methods for hydration of terminal alkynes
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030204041 Ionic liquids
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203899 Drugs for incontinence
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP1355879A1 Carboxamides as fungicides in agriculture
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638975 Treatment of breast cancer
10/28/2003US6638956 Pesticidal 1-arylpyrazoles
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638624 Color filters comprising dyes formed by condensing 1,3-dimethyl-5-pyrazolone with 3,4-dihydroxy-4-cyclobutene-1, 2-dione, then mixing binders and coating on radiation transparent films
10/28/2003CA2136638C New method of combatting insect eggs and ovicidal compositions
10/23/2003WO2003087084A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003WO2003086077A1 Compositions for animal tick or flea control
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003US20030199707 Alkyne ketones
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199536 An amide derivative used as cannabinoid antagonist for the treatment of obesity, schizophrenia, memory dysfunction and marijuana abuse
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199394 Method of purifying a pesticide
10/23/2003US20030198880 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354865A1 Process for the preparation of aromatic aldehydes via ozonolysis of aromatic alkenes
10/22/2003EP1353932A1 Compositions containing a ruthenium(iii) complex and a heterocycle
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1150961B1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
10/22/2003CN1450995A 5-hydroxy indazole derivatives for treating glaucoma
10/22/2003CN1450994A 6-Hydroxy-indazole derivatives for treating glaucoma
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450897A 5HT2 agonists for controlling IOP and treating glaucoma
10/22/2003CN1450049A N-arylating method using amino-acid as additives
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
10/16/2003WO2003085005A1 Photopolymerizable composition
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003US20030195231 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 256